Press Release | NeoGenomics Laboratories

September 26, 2013

NeoGenomics Revises Upward its Quarter 3 2013 Guidance

April 25, 2013

NeoGenomics Reports Record Quarterly Revenue of $15.7 Million, Adjusted EBITDA of $1.8 Million and 46.3% Gross Margin for the First Quarter

April 17, 2013

NeoGenomics Schedules its Q1 2013 Earnings Release for April 25, 2013

February 28, 2013

NeoGenomics Announces Pricing of $9.5 Million Public Offering

February 14, 2013

NeoGenomics Reports 181% Increase in Adjusted EBITDA on 38% Revenue Growth and Achieves Profitability in 2012

February 5, 2013

NeoGenomics Schedules its Q4 and Full Year 2012 Earnings Release for February 14, 2013

December 17, 2012

NeoGenomics Validates and Launches NeoSITE™ Barrett's Esophagus FISH Test for Surveillance and Diagnosis of High Grade Dysplasia/Esophageal Cancer

NeoGenomics Reports 40% Revenue Growth to $122 Million in the Second Quarter

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients